Bile acids are often reduced to a simple digestive function — emulsifying dietary fat in the small intestine. This framing misses the most important point about bile acids: they are hormonal signalling molecules that regulate virtually every aspect of metabolic health. After being synthesised from c

The Bile Acid Revolution

Bile acids are often reduced to a simple digestive function — emulsifying dietary fat in the small intestine. This framing misses the most important point about bile acids: they are hormonal signalling molecules that regulate virtually every aspect of metabolic health. After being synthesised from cholesterol in the liver, bile acids enter the intestine where they act on receptors in the gut, pancreas, brain, and liver itself. These receptors — FXR, TGR5, and others — sense bile acid levels and adjust metabolism accordingly. When bile acid signalling is impaired, metabolic disease follows.

Why Bile Flow Matters

Bile is not just a digestive fluid — it is a mixture of bile acids, cholesterol, bilirubin, phospholipids, and electrolytes. Its composition matters as much as its volume. Bile acid diarrhoea, formerly called cholerheic enteropathy, is a condition where impaired bile acid reabsorption in the terminal ileum produces chronic diarrhoea, bile acid depletion, and fat malabsorption. The condition is underdiagnosed because it mimics IBS and standard stool tests do not differentiate it from other causes of diarrhoea.

The gallbladder stores and concentrates bile between meals, then releases it in response to dietary fat entering the duodenum. This release is regulated by cholecystokinin (CCK), a hormone produced by the small intestine in response to fat and protein. A gallbladder that has been surgically removed does not destroy bile acid production — the liver simply produces bile continuously — but the loss of the storage and concentration function means bile acids reach the distal intestine in higher concentrations, potentially damaging the gut lining and disrupting the microbiome.

Bile Acids and the Microbiome

The gut microbiome metabolises bile acids extensively, converting primary bile acids (chenodeoxycholic acid and cholic acid) into secondary bile acids (deoxycholic acid and lithocholic acid) through bacterial 7alpha-dehydroxylation. These secondary bile acids are far more potent as signalling molecules — deoxycholic acid is a powerful FXR agonist and has antimicrobial properties that regulate the bacterial populations that produce it, creating a feedback loop between host metabolism and microbiome composition. Dysbiosis disrupts this conversion, producing a bile acid pool that is both smaller and less biologically active.

What Impairs Bile Acid Signalling

Common clinical scenarios that disrupt bile acid metabolism include gallbladder removal, ileal disease or resection, small intestinal bacterial overgrowth (SIBO), chronic alcohol consumption, and medications that reduce bile acid reabsorption. Each of these reduces the size or potency of the bile acid pool, with downstream effects on glucose metabolism, lipid metabolism, and gut barrier function. People with these conditions often have a recognisable metabolic signature — elevated LDL despite normal diet, impaired glucose tolerance, and abdominal discomfort after fatty meals.

Supporting Bile Acid Production Naturally

The best support for bile acid metabolism is adequate dietary fat — bile is released in response to fat in the intestine, and without this signal, the gallbladder does not empty properly, leading to bile stasis and altered composition. Intermittent fasting also supports bile acid flux, producing a mild stress on the bile acid system that improves FXR sensitivity. Taurine and glycine conjugation of bile acids, supported by adequate protein intake, produces bile acids that are more water-soluble and less toxic to the gut lining than unconjugated bile acids.

Bile Acid Supplementation as Therapy

Bile acid supplementation — specifically with ursodeoxycholic acid (UDCA) — is used clinically for cholestatic liver disease and gallstone dissolution. More relevantly for the general population, bile acid receptor agonists (FXR agonists) are among the most actively researched drug targets in metabolic medicine, with several pharmaceutical candidates in late-stage trials for NASH, type 2 diabetes, and inflammatory bowel disease. The bile acid system is increasingly recognised as a master metabolic regulator rather than a digestive footnote.

Nutritionally, the most practical bile acid support comes from bovine bile extract supplements, which provide the bile acids needed for fat emulsification in people with impaired bile production or post-cholecystectomy. These are particularly useful for people who have had their gallbladder removed and experience fat malabsorption, loose stools, or fat-soluble vitamin deficiency. The typical dose is 500-1000mg with meals, adjusted based on the fat content of the meal and the individual’s tolerance.

Fat Soluble Vitamins Require Bile

The absorption of fat-soluble vitamins — vitamins A, D, E, and K — requires bile acids for emulsification and micelle formation. Without adequate bile, these vitamins are not absorbed regardless of dietary intake, producing deficiencies that persist even when supplementation is attempted by mouth. This is why post-cholecystectomy patients and people with bile acid malabsorption are at elevated risk for osteoporosis, night blindness, and conditions associated with vitamin E deficiency — the fat-soluble vitamins are simply not being absorbed.

The practical solution for people with impaired bile production is to take fat-soluble vitamins with meals that contain enough fat to stimulate bile release, and to consider supplemental bile acids (ox bile) if fat malabsorption is documented. For vitamin D specifically, which is the most commonly deficient fat-soluble vitamin in northern latitudes, sublingual or injectable forms bypass the gut absorption requirement entirely and are worth considering for people with documented malabsorption.